Prandin (Repaglinide) for Diabetes

Overview
Prandin is a prescription drug approved by the Food and Drug Administration (FDA) to help improve blood glucose control in adults with type 2 diabetes. Prandin is considered an adjunct treatment to diet and exercise. Prandin is also referred to by its drug name, Repaglinide.

Prandin is a meglitinide. Prandin is believed to work by increasing the amount of insulin released by the pancreas.

How do I take it?
Prescribing information states that Prandin is generally taken two, three, or four times a day with meals.

Prandin comes in tablet form.

Side effects
The FDA-approved label for Prandin lists common side effects including hypoglycemia (low blood sugar), back pain, flu-like symptoms, and dizziness.

Rare but serious side effects listed for Prandin include heart problems, blood disorders, and systemic allergic reactions.